Death-specific rate due to asthma and chronic obstructive pulmonary disease in Iran

Clinical Respiratory Journal

Volumn 12, Issue 6, 2018, Pages 2075-2083

  Varmaghani, Mehdi ^a,b   Kebriaeezadeh, Abbas ^c   Sharifi, Farshad ^b   Sheidaei, Ali ^b,d   Rashidian, Arash ^e   Moradi Lakeh, Maziar ^f   Naghshin, Roozbeh ^g   Moin, Mostafa ^h   Mehdipour, Parinaz ^b   Heidari, Elham ^b   Gohari, Kimiya ^b,i   Rezaei, Nazila ^b   Haghshenas, Rosa ^b   Kompani, Farzad ^d   Farzadfar, Farshad ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁱ SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

asthma; COPD; Iran; mortality

Indexed keywords

ADULT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; FEMALE; HUMAN; IRAN; IRANIAN PEOPLE; KERNEL METHOD; MALE; MORTALITY RATE; POPULATION RESEARCH; PRIORITY JOURNAL; STANDARDIZATION; UNCERTAINTY; CAUSE OF DEATH; CLINICAL TRIAL; DEATH CERTIFICATE; EPIDEMIOLOGY; MORTALITY; MULTICENTER STUDY; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRENDS;

ASTHMA; CAUSE OF DEATH; DEATH CERTIFICATES; FEMALE; HUMANS; IRAN; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 85045414982     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12776     Document Type: Article

References (34)

1. Lopez AD. Causes of death in industrial and developing countries: estimates for 1985–1990. 1993.
2. Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. Seattle WI, University of Washington, 2016. Available from: http://vizhub.healthdata.org/gbd-compare
3. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555.
4. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
5. Aït-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ. 2001;79(10):971–979.
6. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773. https://doi.org/10.1016/s0140-6736(07)61380-4.
7. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. Respir Care. 2002;47(10):1184–1199.
8. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128.
9. Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health. 2011;39(suppl 7):26–29.
10. Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–424.
11. Murray CJ, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063–2066.
12. Farzadfar F, Delavari A, Malekzadeh R, et al. NASBOD 2013: design, definitions, and metrics. Arch Iran Med. 2014;17(1):7–15. https://doi.org/0141701/aim.004. [24444059]
13. Mohammadi Y, Parsaeian M, Farzadfar F, et al. Levels and trends of child and adult mortality rates in the Islamic Republic of Iran, 1990–2013; protocol of the NASBOD study. Arch Iran Med. 2014;17(3):176–181. https://doi.org/0141703/aim.007.
14. Sheidaei A, Gohari K, Kasaeian A, et al. National and subnational patterns of cause of death in Iran 1990–2015: applied methods. Arch Iran Med. 2017;20(1):2–11. https://doi.org/0172001/aim.003.
15. Keiding N. Extinction and exponential growth in random environments. Theor Popul Biol. 1975;8(1):49–63.
16. Mehdipour P, Navidi I, Parsaeian M, et al. Application of Gaussian Process Regression (GPR) in estimating under-five mortality levels and trends in Iran 1990 - 2013, study protocol. Arch Iran Med. 2014;17(3):189–192. https://doi.org/0141703/aim.009.
17. Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr. 2012;10(1):1.
18. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370(9589):741–750.
19. De Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985.
20. Graudenz GS, Gazotto GP. Mortality trends due to chronic obstructive pulmonary disease in Brazil. Revista da Associação Médica Brasileira. 2014;60(3):255–261.
21. Lopez A, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412.
22. Marcon A, Saugo M, Fedeli U. COPD-related mortality and co-morbidities in Northeastern Italy, 2008–2012: a multiple causes of death analysis. J Chronic Obstruct Pulm Dis. 2016;13(1):35–41.
23. Varmaghani M, Farzadfar F, Sharifi F, et al. Prevalence of asthma, COPD, and chronic bronchitis in Iran: a systematic review and meta-analysis. Iran J Allergy Asthma Immunol. 2016;15(2):93–104.
24. Atash F. The deterioration of urban environments in developing countries: mitigating the air pollution crisis in Tehran, Iran. Cities. 2007;24(6):399–409.
25. Ko FW, Tam W, Wong TW, et al. Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong. Thorax. 2007;62(9):780–785.
26. Lee S, Wong W, Lau Y. Association between air pollution and asthma admission among children in Hong Kong. Clin Exp Allergy. 2006;36(9):1138–1146.
27. Kurt OK, Zhang J, Pinkerton KE. Pulmonary health effects of air pollution. Curr Opin Pulm Med. 2016;22(2):138–143. https://doi.org/10.1097/MCP.0000000000000248.
28. Ling SH, van Eeden SF. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulm Dis. 2009;4:233–243.
29. Guilbert JJ. The World Health Report 2002—reducing risks, promoting healthy life. Educ Health. 2003;16(2):230. https://doi.org/10.1080/1357628031000116808.
30. Meysamie A, Ghaletaki R, Haghazali M, et al. Pattern of tobacco use among the Iranian adult population: results of the national Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007). Tob Control. 2010;19(2):125–128.
31. Mohammadpoorasl A. Increasing the trend of smoking in Iranian adolescents. Iran J Public Health. 2013;42(10):1197–1198.
32. Humerfelt S, Gulsvik A, Skjaerven R, et al. Decline in FEV1 and airflow limitation related to occupational exposures in men of an urban community. Eur Respir J. 1993;6(8):1095–1103.
33. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706. https://doi.org/10.1016/s2213-2600(17)30293-x.
34. Yin P, Jiang C, Cheng K, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007;370(9589):751–757.